Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
Molecular Weight | 718.8 g/mol |
---|---|
Molecular Formula | C40H38N4O7S |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 5 |
Exact Mass | 718.24612074 g/mol |
Monoisotopic Mass | 718.24612074 g/mol |
Topological Polar Surface Area | 172 A^2 |
Heavy Atom Count | 52 |
Formal Charge | 0 |
Complexity | 1110 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Zyprexa relprevv |
Active Ingredient | Olanzapine pamoate |
Dosage Form | Suspension, extended release |
Route | Intramuscular |
Strength | eq 300mg base/vial; eq 210mg base/vial; eq 405mg base/vial |
Market Status | Prescription |
Company | Eli Lilly |
2 of 2 | |
---|---|
Drug Name | Zyprexa relprevv |
Active Ingredient | Olanzapine pamoate |
Dosage Form | Suspension, extended release |
Route | Intramuscular |
Strength | eq 300mg base/vial; eq 210mg base/vial; eq 405mg base/vial |
Market Status | Prescription |
Company | Eli Lilly |
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?